ELISA Kits

Antibodies

Primary Antibodies

PGP9.5

GFAP

NEUROFILAMENT

MYBPC3

B7-1

D-DIMER

FABP3

IGG4

IL17

MYELOPEROXIDASE

N PROTEIN

NGAL

REG1 ALPHA

S PROTEIN

S100 BETA

S100A8/A9

SARS-COV-2 N PROTEIN

SARS-COV-2 SPIKE PROTEIN

SERUM AMYLOID A

ST2

BETA 2 MICROGLOBULIN

IL6

PD-L1

PD1

PON1

PSMA

S100A1

B RAF

MSMB

Human

SARS-CoV-2

Mouse

Rat

Dog

Human (Does not react with: Mouse)

Monkey

ELISA

WB

FC

IHC

LMNX

IF

Neutralize

IP

Mouse

KO Validated Antibodies

Unconjugated

IgG1

IgG2b

IgG2a

Monoclonal

Indirect

TrueMAB

Druggable Genome

Secreted Protein

ES Cell Differentiation/IPS

Transmembrane

Protease

Transcription Factors

Protein Kinase

Parkinson's disease

Cell adhesion molecules (CAMs)

Hypertrophic cardiomyopathy (HCM)

Amyotrophic lateral sclerosis (ALS)

Graft-versus-host disease

Toll-like receptor signaling pathway

Cytokine-cytokine receptor interaction

Dilated cardiomyopathy

Allograft rejection

Autoimmune thyroid disease

Systemic lupus erythematosus

Type I diabetes mellitus

Viral myocarditis

PPAR signaling pathway

Pathways in cancer

Antigen processing and presentation

Cytosolic DNA-sensing pathway

Hematopoietic cell lineage

Jak-STAT signaling pathway

Metabolic pathways

NOD-like receptor signaling pathway

Prion diseases

T cell receptor signaling pathway

Acute myeloid leukemia

Bladder cancer

Chemokine signaling pathway

Chronic myeloid leukemia

Colorectal cancer

Endometrial cancer

ErbB signaling pathway

Focal adhesion

Glioma

Insulin signaling pathway

Long-term depression

Long-term potentiation

MAPK signaling pathway

Melanoma

Natural killer cell mediated cytotoxicity

Neurotrophin signaling pathway

Non-small cell lung cancer

Pancreatic cancer

Progesterone-mediated oocyte maturation

Prostate cancer

Regulation of actin cytoskeleton

Renal cell carcinoma

Thyroid cancer

Vascular smooth muscle contraction

mTOR signaling pathway

Carrier-free Antibodies

1